C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/16/2004	US20040253622 Androgen regulated prostate specific polypeptide-5 (ARP-5)
12/16/2004	US20040253621 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
12/16/2004	US20040253620 Using insertional events to transfer genetic material to cells, expressing nucleotide sequences, translating products and identifying allelic variants via electrophoretic separation
12/16/2004	US20040253619 Methods for rapid detection and identification of bacterial bioagents
12/16/2004	US20040253617 Using capsular polysaccharide gene (CPS) sequences to classify streptococcal serotypes; diagnosis and treatment of infection
12/16/2004	US20040253614 Multicompartment device comprising microarrays which utilizes computer imaging to monitor and analyze genetic hybridization events in liquids; computer diagnostic imaging
12/16/2004	US20040253613 Preparing biopolymer immobilized matricies for use as tool in cell assays and sequencing via hybridization; gel microarrays
12/16/2004	US20040253612 Selection of proteins using RNA-protein fusions
12/16/2004	US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders
12/16/2004	US20040253609 Prostate cancer markers
12/16/2004	US20040253606 Using tumor marker gene transcription profile as diagnostic tool in detection of cell proliferative disorders of soft tissue; monitoring efficacy of antitumor agents
12/16/2004	US20040253603 Using dextran sulfate as volume exclusion agent for enhancing hybridization; automated in situ/vitro hybridization
12/16/2004	US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator
12/16/2004	US20040253594 Using polymorphic nucleotide sequences to identify regions/quantitative trait loci for natural resistance-associated macrophage protein (NRAMP) genes; prognosticating parasitic infection resistance
12/16/2004	US20040253593 Quenching methods for background reduction in luminescence-based probe-target binding assays
12/16/2004	US20040253591 Compositions and methods for making mutations in cell lines and animals
12/16/2004	US20040253590 Compositions and methods for making mutations in cell lines and animals
12/16/2004	US20040253589 Compositions and methods for making mutations in cell lines and animals
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253585 Methods of detecting polynucleotide kinase and its use as a label
12/16/2004	US20040253584 Method for separating nucleic acids into populations
12/16/2004	US20040253583 Methods for rapid detection and identification of viral bioagents
12/16/2004	US20040253582 Method of detecting the presence of a target nucleic acid via a multiplex amplification reaction using unequal primer concentration
12/16/2004	US20040253578 Solid support comprising immobilized dynamic action reference tools (DART)/bioconjugates for use in isolation and analysis of nucleic acids and polypeptides; drug screening
12/16/2004	US20040253574 Method for producing ready to use, antigen loaded or unloaded, cryconserved mature dendritic cells
12/16/2004	US20040253460 Functionalized silicon compounds and methods for their synthesis and use
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis
12/16/2004	US20040253220 amino acid sequences of human oxidoreductase enzymes, used for activating expression of elastin; cosmetics
12/16/2004	US20040253216 Activated checkpoint therapy and methods of use thereof
12/16/2004	US20040253211 analyzing the expression of claudin-3, claudin-4 and claudin-9; if these genes are under-expressed, the transformed/cancerous cell is a metastatic cell; nucleic acid is transfected into the cancerous cell
12/16/2004	US20040253141 Apparatus and method for nucleic acid spatial ordering
12/16/2004	US20040252299 Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
12/16/2004	US20040251132 Electrochemical strips for the detection of glucose or of analytes such as lactate, hemoglobin, and hydrogen peroxide, particularly wherein the walls of the adhesive layer touch or overlap with the reagent layer; test strips with small sample chambers
12/16/2004	US20040251131 Biosensor, biosensor chip, and biosensor device
12/16/2004	DE10323081A1 Verwendung eines Polypeptides Use of a polypeptide
12/16/2004	DE10323069A1 Chemical or physical treatment of e.g. bacteria in agar comprises stabilizing encapsulation material on frame with handle and increasing substance interchange between it and reaction solution using counter-flow technique
12/16/2004	DE10322912A1 Verfahren zum Nachweis von Nukleinsäuren A method for detecting nucleic acids
12/16/2004	DE10322282A1 Automated genotyping, useful e.g. for assessing risk of developing thrombosis, comprises hybridization to a microarray of probes and evaluation against a control standard to indicate target sequences that can not be evaluated
12/16/2004	CA2568806A1 Methods for detecting and treating cancer using podocalyxin and/or endoglycan
12/16/2004	CA2540692A1 Oligonucleotide synthesis with alternative solvents
12/16/2004	CA2528830A1 Transducible dna-binding proteins
12/16/2004	CA2528508A1 System and method for multidimensional evaluation of combinations of compositions
12/16/2004	CA2528131A1 Nucleotides for prevention and treatment of bacterial and fungal pathologies
12/16/2004	CA2528088A1 Method for diagnosing cancer and method for determining cancer susceptibility
12/16/2004	CA2527947A1 Methods for assessing the invasive potential of a cell employing chromatin analysis
12/16/2004	CA2527799A1 Methods for identifying modulators of kinesin activity
12/16/2004	CA2527721A1 Chimeric adenovirus capsid proteins
12/16/2004	CA2527650A1 Method for identification of glycosylated polypeptides
12/16/2004	CA2527323A1 Methods for predicting drug efficacy in patients afflicted with hypertension
12/16/2004	CA2527320A1 Methods and compositions for predicting irinotecan toxicity
12/16/2004	CA2526515A1 Methods for screening inhibitors of apoptosis
12/16/2004	CA2526012A1 Screen for novel protein inhibitors based upon engineered cell line containing an inducible overactivity gene and compensatory gene
12/15/2004	EP1486785A1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof
12/15/2004	EP1486778A2 Electrochemical biosensor
12/15/2004	EP1486562A1 Method of examining allergic disease
12/15/2004	EP1486561A1 Probe medium
12/15/2004	EP1486510A1 Transporter gene OATP- C
12/15/2004	EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition
12/15/2004	EP1486211A1 Compositions for treating cancer using viruses
12/15/2004	EP1485714A2 Methods for the detection of prion proteins
12/15/2004	EP1485709A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
12/15/2004	EP1485707A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
12/15/2004	EP1485506A2 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes
12/15/2004	EP1485505A1 Melting temperature dependent dna amplification
12/15/2004	EP1485504A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
12/15/2004	EP1485503A2 Improved nucleic acid amplification
12/15/2004	EP1485502A2 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof
12/15/2004	EP1485501A2 Method for generating amplified rna
12/15/2004	EP1485499A1 Novel primers for screening schizophrenia and a method thereof
12/15/2004	EP1485498A2 Synthesis of synthons for the manufacture of bioactive compounds
12/15/2004	EP1485491A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
12/15/2004	EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels
12/15/2004	EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof
12/15/2004	EP1485480A2 Cd40 splice variants, method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
12/15/2004	EP1485477A2 Novel type-1 cytokine receptor glm-r
12/15/2004	EP1485467A2 Recombinant expression vectors for functional na sb v /sb 1.9 sodium channels
12/15/2004	EP1485466A2 Methods for treating diseases or conditions with peptide constructs
12/15/2004	EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
12/15/2004	EP1485406A2 Highly homogeneous molecular markers for electrophoresis
12/15/2004	EP1485405A2 Melanin-concentrating hormone analogs
12/15/2004	EP1485402A2 Selective extraction of dna from groups of cells
12/15/2004	EP1485399A2 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS
12/15/2004	EP1485398A2 Methods of screening for compounds that modulate hormone receptor activity
12/15/2004	EP1485397A2 Trans-splicing mediated imaging of gene expression
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485129A2 Nanostructures containing pilin protein
12/15/2004	EP1485128A2 Nanostructures containing antibody assembly units
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485056A2 Methods of using fet labeled oligonucleotides that include a'5' exonuclease resistant quencher domain and compositions for practicing the same
12/15/2004	EP1461453A4 Methods of identifying cellular target molecules
12/15/2004	EP1444363A4 Transfection kinetics and structural promoters
12/15/2004	EP1425065A4 Electrical field stimulation of eukaryotic cells
12/15/2004	EP1421176A4 Nucleic acids and encoded polypeptides associated with bipolar disorder

1 ... 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 ... 3003